🇺🇸 FDA

Company profile · Sponsor

REVIVA

REVIVA PHARMACEUTICALS HOLDINGS, INC.

RVPH · NYSE pharma CUPERTINO, CA, USA
Pipeline
3
Drugs
0
Patents
8

Quick answer

REVIVA (RVPH) is a pharma company. headquartered in CUPERTINO, CA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker RVPH
Exchange NYSE
Company type pharma
Headquarters CUPERTINO, CA, USA
SEC CIK 0001742927

Pipeline (3)

Search pipeline →

  1. Brilaroxazine

    REVIVA

    Schizophrenia

    phase 3 small molecule active

    1 trial

  2. RP5063

    REVIVA

    Acute Schizophrenia

    phase 2 small molecule completed

    1 trial

  3. Lipoaspiration

    REVIVA

    Hereditary Corneal Dystrophy

    phase 1 other active

    1 trial

Patents (8)

Search patents →

  1. US 12053477

    Methods for treating pulmonary fibrosis

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10441590

    Methods for treating pulmonary hypertension

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10035761

    Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

    Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9975862

    Arylpiperazine derivatives and methods of utilizing same

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9907803

    Methods for treating attention deficit hyperactivity disorder

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9695116

    Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9604944

    Arylpiperazine derivatives and methods of utilizing same

    Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9302981

    Synthesis, methods of using, and compositions of cycloalkylmethylamines

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is REVIVA?

REVIVA (RVPH) is a pharma company. headquartered in CUPERTINO, CA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does REVIVA sponsor?

We track 3 ClinicalTrials.gov-linked programs for REVIVA, including Brilaroxazine and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does REVIVA company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.